Jammu to pioneer India’s first Cannabis Medicine Project

The ‘Cannabis Research Project’ of CSIR-IIIM Jammu, spearheaded by Prime Minister Narendra Modi, marks the first-ever initiative of its kind in India. This groundbreaking project is carried out in partnership with a Canadian firm ‘IndusScan’ with the aim of harnessing the potential of cannabis, a substance known for its abuse potential, for the benefit of humanity, particularly for patients afflicted with neuropathies, cancer, and epilepsy.

The Historic Collaboration Between CSIR-IIIM and IndusScan

The historic scientific agreement signed between CSIR-IIIM and IndusScan holds immense significance not only for J&K but also for the entire nation. It has the potential to revolutionize medicine production, ensuring that the country can produce and export medicines that were previously sourced from foreign countries.

This project will play a significant role in raising awareness about the diverse medicinal applications of this once-abused substance, particularly in providing relief to patients suffering from malignancies and various other diseases.

From the perspective of Atma-Nirbhar Bharat (self-reliant India), once all the necessary approvals are obtained, this initiative will enable the production of high-quality drugs suitable for treating different types of neuropathies, diabetic pains, and more, fostering self-sufficiency in the pharmaceutical sector.

CSIR-IIIM: Pioneering Scientific Research in India

CSIR-IIIM, the oldest scientific research institute in India, boasts a rich history of groundbreaking discoveries, including the identification of mint in the 1960s and its pivotal role in the purple revolution. Now, with the advent of the Cannabis Research Project, CSIR-IIIM is poised to elevate its status even further, cementing its position as a prestigious hub for scientific research in India.

Advancements in Medical Cannabis

Cannabis, a remarkable plant, has led to the approval of several drugs by the FDA, including Marilnol/nabilone and Cesamet, prescribed for managing nausea and vomiting. Sativex is another FDA-approved drug that utilizes cannabis for treating neuropathic pain and spasticity, while Epidiolex, containing Cannabidiol, has shown promising results in treating epilepsy. Furthermore, cannabis is being utilized for various medical purposes in other countries as well.

Key takeaways for competitive examinations

  • Chief Scientist at CSIR-IIIM Jammu: Dr Zabeer Ahmed

Find More Miscellaneous News Here

saurabh

Recent Posts

Australia Clinch Record Seventh ICC Women’s T20 World Cup Title

The most successful team of Women's T20 cricket world cup history, Australia defeated host nation…

2 hours ago

FIFA World Cup 2026 Round of 16 Fixtures: Full Schedule, Results and Venues

After the Round of 32 of the 2026 FIFA World Cup concluded and a total…

8 hours ago

2026 FIFA World Cup Top Scorers: Latest Golden Boot Standings

The race for the FIFA World Cup 2026 Golden Boot has become the most exciting…

8 hours ago

Weekly Current Affairs One Liners (29th June to 5th July, 2026)

Weekly Current Affairs One-Liners Current Affairs 2026 plays a very important role in competitive examinations…

9 hours ago

Vaibhav Sooryavanshi Becomes Youngest India Debutant at 15

On 4th of July, 2026 Vaibhav Sooryavanshi became the youngest player ever to play for…

1 day ago

Current Affairs Capsule PDF (4 July, 2026)

National News UIDAI Launches Free Email Update Service in Aadhaar App: Everything You Need to…

1 day ago